Implementation of “clinical sequencing” in cancer genome medicine in Japan
Author:
Affiliation:
1. Division of Genome Biology; National Cancer Center Research Institute; Tokyo Japan
2. Division of Translational Genomics; Exploratory Oncology Research and Clinical Trial Center; National Cancer Center; Tokyo Japan
Funder
Japan Agency for Medical Research and Development
National Cancer Center Research and Development Fund
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13486/fullpdf
Reference34 articles.
1. Defining actionable mutations for oncology therapeutic development;Carr;Nat Rev Cancer,2016
2. Crizotinib in ROS1-rearranged non-small-cell lung cancer;Shaw;N Engl J Med,2014
3. Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial;Yoh;Lancet Respir Med,2017
4. KIF5B-RET fusions in lung adenocarcinoma;Kohno;Nat Med,2012
5. Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial;Planchard;Lancet Oncol,2017
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Young Adult Secondary Cancer After Proton Beam Therapy: A Case Study;Advances in Radiation Oncology;2024-01
2. Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study;Japanese Journal of Clinical Oncology;2023-10-28
3. The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan;Cancer Biology & Medicine;2023-05-03
4. Fractal correlations in the Covid-19 genome sequence via multivariate rescaled range analysis;Chaos, Solitons & Fractals;2023-03
5. Mission of the National Cancer Center Hospital in Japan to promote clinical trials for precision medicine;Cancer Biology & Medicine;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3